Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
出版年份 2023 全文链接
标题
Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
作者
关键词
-
出版物
Pharmacological Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-31
DOI
10.1007/s43440-023-00544-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Endocannabinoid System and Physical Exercise
- (2023) Daniela Matei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- THC and CBD: Similarities and differences between siblings
- (2023) Nephi Stella NEURON
- Cannabidiol Rescues TNF-α-Inhibited Proliferation, Migration, and Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells
- (2023) Lina Yu et al. Biomolecules
- Endocannabinoid System: Chemical Characteristics and Biological Activity
- (2023) Bismarck Rezende et al. Pharmaceuticals
- An enquiry to the role of CB1 receptors in neurodegeneration
- (2023) Ignacio Fernández-Moncada et al. NEUROBIOLOGY OF DISEASE
- CB2 receptor in the CNS: From immune and neuronal modulation to behavior
- (2023) Wanda Grabon et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- An analysis of the nutritional effects of Schisandra chinensis components based on mass spectrometry technology
- (2023) Mengzhen Jia et al. Frontiers in Nutrition
- A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
- (2022) Jiangling Peng et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells
- (2022) Sunhee Jang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects
- (2022) Si-Jing Hu et al. MOLECULES
- Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
- (2022) Christopher A. Legare et al. PHARMACOLOGY
- Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease
- (2022) Mengya Wang et al. Frontiers in Cellular Neuroscience
- Expression and Functions of the CB2 Receptor in Human Leukocytes
- (2022) Mélissa Simard et al. Frontiers in Pharmacology
- Impact of cannabinoids on pregnancy, reproductive health and offspring outcomes
- (2022) Jamie O. Lo et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- A mechanistic review on immunomodulatory effects of selective type two cannabinoid receptor β‐caryophyllene
- (2022) Vafa Baradaran Rahimi et al. BIOFACTORS
- Review of delta‐8‐tetrahydrocannabinol (Δ 8 ‐THC): Comparative pharmacology with Δ 9 ‐THC
- (2022) Michael Tagen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis
- (2022) Wenjing Du et al. PHYTOMEDICINE
- Schisandrin B targets cannabinoid 2 receptor in Kupffer cell to ameliorate CCl4-induced liver fibrosis by suppressing NF-κB and p38 MAPK pathway
- (2022) Hai-Qiao Wang et al. PHYTOMEDICINE
- Structural insights into TRPV2 activation by small molecules
- (2022) Ruth A. Pumroy et al. Nature Communications
- Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
- (2022) Amaya Austrich-Olivares et al. Pharmaceuticals
- Curcumin Protects Diabetic Mice against Isoproterenol-Induced Myocardial Infarction by Modulating CB2 Cannabinoid Receptors
- (2022) Harshal D. Pawar et al. Life-Basel
- Synthetic Cannabinoids: A Pharmacological and Toxicological Overview
- (2022) Rita Roque-Bravo et al. Annual Review of Pharmacology and Toxicology
- Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells
- (2022) Hee-Seop Lee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials
- (2022) Tácio de Mendonça Lima et al. ANIMAL HEALTH RESEARCH REVIEWS
- Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
- (2022) Hiroki Ishiguro et al. Frontiers in Psychiatry
- An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma
- (2022) Emily K. Colvin et al. Cancers
- β-caryophyllene modulates B-cell lymphoma gene-2 family genes and inhibits the intrinsic pathway of apoptosis in isoproterenol-induced myocardial infarcted rats; A molecular mechanism
- (2022) Anita Yovas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
- (2022) Mendhi Henna Dasram et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
- (2022) Elliot D. Mock et al. PROGRESS IN LIPID RESEARCH
- Molecular Insights into Epigenetics and Cannabinoid Receptors
- (2022) Balapal S. Basavarajappa et al. Biomolecules
- Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
- (2022) Ana Tadijan et al. Antioxidants
- Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
- (2022) Barbara Vuic et al. Biomedicines
- On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors
- (2021) Mariangela Pucci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action
- (2021) Yane Costa Chaves et al. METABOLIC BRAIN DISEASE
- What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?
- (2021) Piotr Schulz et al. Nutrients
- Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages
- (2021) Seegehalli M. Anil et al. Scientific Reports
- β-caryophyllene, a natural bicyclic sesquiterpene attenuates β-adrenergic agonist-induced myocardial injury in a cannabinoid receptor-2 dependent and independent manner
- (2021) M.F. Nagoor Meeran et al. FREE RADICAL BIOLOGY AND MEDICINE
- Involvement of CB2 signalling pathway in the development of osteoporosis by regulating the proliferation and differentiation of hBMSCs
- (2021) Feng Tian et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Alzheimer's disease
- (2021) Philip Scheltens et al. LANCET
- Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
- (2021) Zeinab Breijyeh et al. Toxins
- Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2021) Tiffany M. Powell-Wiley et al. CIRCULATION
- A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses anxiolytic-like activity with neuroprotective effect through the modulation of CB1 receptor
- (2021) Vittoria Borgonetti et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand
- (2021) Bruno M. Fonseca et al. Reproductive Sciences
- β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
- (2021) Niraj Kumar Jha et al. Frontiers in Pharmacology
- 3-Hydroxypropane-1,2-Diyl Dipalmitoleate—A Natural Compound with Dual Roles (CB1 Agonist/FAAH1 Blocker) in Inhibiting Ovarian Cancer Cell Line
- (2021) Christina Vijayaraghavan Sathynathan et al. Pharmaceuticals
- A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid
- (2021) Hebaallah Mamdouh Hashiesh et al. BIOMEDICINE & PHARMACOTHERAPY
- The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
- (2021) David Cabañero et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action
- (2021) Andrzej L. Dawidowicz et al. FITOTERAPIA
- The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
- (2021) Henry Lowe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoids in the landscape of cancer
- (2021) Nagina Mangal et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome
- (2021) X. Qi et al. JOURNAL OF DENTAL RESEARCH
- The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization
- (2021) Astrid Coronado-Álvarez et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Immunoporosis: Role of Innate Immune Cells in Osteoporosis
- (2021) Yogesh Saxena et al. Frontiers in Immunology
- Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
- (2021) Yinyi Xiong et al. Brain Sciences
- The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
- (2021) Martina Rabino et al. Pharmaceuticals
- Risks and Benefits of Cannabis and Cannabinoids in Psychiatry
- (2021) Kevin P. Hill et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
- (2021) Benjamin J. Moss et al. Annual Review of Pathology-Mechanisms of Disease
- 1-, 2- and 3-AG as substrates of the endocannabinoid enzymes and endogenous ligands of the cannabinoid receptor 1
- (2021) Shrouq I. Farah et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An overview on plants cannabinoids endorsed with cardiovascular effects
- (2021) Marilisa Pia Dimmito et al. BIOMEDICINE & PHARMACOTHERAPY
- Mechanism deconvolution of Qing Fei Pai Du decoction for treatment of Coronavirus Disease 2019 (COVID-19) by label-free integrative pharmacology assays
- (2021) Fangfang Xu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
- (2021) Damian F Santomauro et al. LANCET
- Cannabinoids—Characteristics and Potential for Use in Food Production
- (2021) Joanna Kanabus et al. MOLECULES
- Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
- (2021) Antonella Capozzi et al. MOLECULES
- Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
- (2021) Iu Raïch et al. PHARMACOLOGICAL RESEARCH
- Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review
- (2021) Szymon Hryhorowicz et al. Frontiers in Immunology
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease
- (2021) Takefumi Kimura et al. Frontiers in Endocrinology
- The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
- (2021) Robert Ramer et al. Cancers
- The peripheral CB 1 receptor antagonist JD5037 attenuates liver fibrosis via a CB 1 receptor /β‐arrestin1/ Akt pathway
- (2020) Siwei Tan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
- (2020) Tian Hua et al. CELL
- Activation of cannabinoid receptor type 2-induced osteogenic differentiation involves autophagy induction and p62-mediated Nrf2 deactivation
- (2020) Aihua Xu et al. Cell Communication and Signaling
- Cannabinoids as anticancer therapeutic agents
- (2020) Olga Kovalchuk et al. CELL CYCLE
- Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease
- (2020) Han Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic efficacy of Qingfei Paidu decoction combined with antiviral drugs in the treatment of corona virus disease 2019
- (2020) Kai Gao et al. MEDICINE
- A Comprehensive Review on Schisandrin B and Its Biological Properties
- (2020) M. I. Nasser et al. Oxidative Medicine and Cellular Longevity
- Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
- (2020) Gemma Navarro et al. PHARMACOLOGICAL RESEARCH
- Identification of a novel tumor angiogenesis inhibitor targeting Shh/Gli1 signaling pathway in Non-small cell lung cancer
- (2020) Xueping Lei et al. Cell Death & Disease
- β-Caryophyllene Inhibits Cell Proliferation through a Direct Modulation of CB2 Receptors in Glioblastoma Cells
- (2020) Natasha Irrera et al. Cancers
- Antidepressant-Like Effect of Terpineol in an Inflammatory Model of Depression: Involvement of the Cannabinoid System and D2 Dopamine Receptor
- (2020) Graziela Vieira et al. Biomolecules
- Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway
- (2020) Agnese Gugliandolo et al. FITOTERAPIA
- Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
- (2020) Dongchen An et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of Peroxisome Proliferator-Activated Receptors (PPAR) in immune responses
- (2020) Anthos Christofides et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Review of the Endocannabinoid System
- (2020) Hui-Chen Lu et al. Biological Psychiatry-Cognitive Neuroscience and Neuroimaging
- Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands
- (2020) Jing-Fang Yang et al. ACS Chemical Neuroscience
- Curcumin inhibits the formation of atherosclerosis in ApoE mice by suppressing cytomegalovirus activity in endothelial cells
- (2020) Ya-li Lv et al. LIFE SCIENCES
- Epigenetics and the endocannabinoid system signaling: An intricate interplay modulating neurodevelopment
- (2020) Telma Marisa Gomes et al. PHARMACOLOGICAL RESEARCH
- Transient receptor potential channels: current perspectives on evolution, structure, function and nomenclature
- (2020) Nathaniel J. Himmel et al. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Shared Binding Mode of Perrottetinene and Tetrahydrocannabinol Diastereomers inside the CB1 Receptor May Incentivize Novel Medicinal Drug Design: Findings from an in Silico Assay
- (2020) Matheus Henrique Reis et al. ACS Chemical Neuroscience
- CB2 receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in SARS‐CoV ‐2 infections
- (2020) M. F. Meeran et al. DRUG DEVELOPMENT RESEARCH
- The Cannabis Terpenes
- (2020) Sarana Rose Sommano et al. MOLECULES
- Immune suppression in the early stage of COVID-19 disease
- (2020) Wenmin Tian et al. Nature Communications
- Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex
- (2020) Elizabeth A. Thiele et al. JAMA Neurology
- Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
- (2020) Amir Garakani et al. Frontiers in Psychiatry
- Hemopressin as a breakthrough for the cannabinoid field
- (2020) Andrea S. Heimann et al. NEUROPHARMACOLOGY
- Cannabinoid Ligands Targeting TRP Channels
- (2019) Chanté Muller et al. Frontiers in Molecular Neuroscience
- Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis
- (2019) Mario Stampanoni Bassi et al. Frontiers in Neurology
- Cannabimimetic plants: are they new cannabinoidergic modulators?
- (2019) Amit Kumar et al. PLANTA
- Positive and Negative Effects of Cannabis and Cannabinoids on Health
- (2019) Koby Cohen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cannabinoid-sensitive receptors in cardiac health and disease
- (2019) Sarah-Lena Puhl BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB2) receptors in rats
- (2019) M.F. Nagoor Meeran et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Structural Insights into CB1 Receptor Biased Signaling
- (2019) Al-Zoubi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
- (2019) Arulkumar Nagappan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tools for Understanding Nanoscale Lipid Regulation of Ion Channels
- (2019) Carol V. Robinson et al. TRENDS IN BIOCHEMICAL SCIENCES
- Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and its Downstream Signaling Pathways in Metastatic Colorectal Cancer
- (2019) Valeria Tutino et al. Cancers
- Cannabinoid receptors in osteoporosis and osteoporotic pain: a narrative update of review
- (2019) Jing Wang et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- PPARs as Nuclear Receptors for Nutrient and Energy Metabolism
- (2019) Fan Hong et al. MOLECULES
- β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors
- (2019) Natasha Irrera et al. Biomolecules
- A selective CB2 agonist protects against the inflammatory response and joint destruction in collagen-induced arthritis mice
- (2019) Jiaxiang Bai et al. BIOMEDICINE & PHARMACOTHERAPY
- Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
- (2019) V. L. J. Proesmans et al. LUNG
- Cannabidiol (CBD) use in psychiatric disorders: A systematic review
- (2019) Stefania Bonaccorso et al. NEUROTOXICOLOGY
- Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury
- (2019) Milad Ashrafizadeh et al. CURRENT MOLECULAR MEDICINE
- β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain
- (2019) Esraa Aly et al. MOLECULES
- Phytochemicals targeting matrix metalloproteinases regulating tissue degradation in inflammation and rheumatoid arthritis
- (2019) Alamgeer et al. PHYTOMEDICINE
- Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis
- (2019) Xingwu Jiang et al. PHYTOMEDICINE
- Constituyentes psicoactivos del cannabis y sus implicaciones clínicas: una revisión sistemática
- (2018) Cristina Casajuana Köguel et al. Adicciones
- Alzheimer’s disease paper 1: clinical update on epidemiology, pathophysiology and diagnosis
- (2018) Dhamidhu Eratne et al. Australasian Psychiatry
- β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity
- (2018) Guifang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Catechol-O-methyltransferase, Cognition and Alzheimer's Disease
- (2018) Matea Nikolac Perkovic et al. Current Alzheimer Research
- Hypocholesterolemic effect of β-caryophyllene in rats fed cholesterol and fat enriched diet
- (2018) Amani A. Harb et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
- (2018) Blathnaid Hughes et al. NEUROCHEMICAL RESEARCH
- Liver fibrosis
- (2018) M. Merve Aydin et al. Turkish Journal of Gastroenterology
- Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview
- (2018) G. M. Mandolini et al. Epidemiology and Psychiatric Sciences
- Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
- (2018) Claudia A. Dumitru et al. Frontiers in Molecular Neuroscience
- α-Terpineol, a natural monoterpene: A review of its biological properties
- (2018) Christina Khaleel et al. Open Chemistry
- Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy
- (2018) Maria J. Casarejos et al. JOURNAL OF ALZHEIMERS DISEASE
- Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer's Disease
- (2018) Gaurav Bedse et al. JOURNAL OF ALZHEIMERS DISEASE
- β-Caryophyllene, the major constituent of copaiba oil, reduces systemic inflammation and oxidative stress in arthritic rats
- (2018) Ana P. Ames-Sibin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
- (2018) Maurizio Parola et al. MOLECULAR ASPECTS OF MEDICINE
- Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma
- (2018) Francieli Vuolo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoid receptor 2 agonist prevents local and systemic inflammatory bone destruction in rheumatoid arthritis
- (2018) Mo Zhu et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high
- (2018) A. Chicca et al. Science Advances
- Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease
- (2018) Marco Gentili et al. PHARMACOLOGICAL RESEARCH
- Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors
- (2018) Dareen A. Youssef et al. BIOMEDICINE & PHARMACOTHERAPY
- Polysaccharopeptide from Trametes versicolor blocks inflammatory osteoarthritis pain-morphine tolerance effects via activating cannabinoid type 2 receptor
- (2018) Kai Wang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Is there a potential of misuse for Magnolia officinalis compounds/metabolites?
- (2017) Fabrizio Schifano et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- (−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis
- (2017) Thaís Alberti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents
- (2017) Mélanie Poivre et al. Journal of Zhejiang University-SCIENCE B
- Systemic sclerosis
- (2017) Christopher P Denton et al. LANCET
- Rutamarin, an active constituent from Ruta angustifolia Pers., induced apoptotic cell death in the HT29 colon adenocarcinoma cell line
- (2017) SriNurestri Abdul Malek et al. Pharmacognosy Magazine
- Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease
- (2017) S. Badal et al. PHARMACOLOGY & THERAPEUTICS
- The effect of β-caryophyllene on nonalcoholic steatohepatitis
- (2017) Naoya Arizuka et al. Journal of Toxicologic Pathology
- Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation
- (2017) Sabrina Giacoppo et al. Multiple Sclerosis and Related Disorders
- The CB2 receptor and its role as a regulator of inflammation
- (2016) Caroline Turcotte et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
- (2016) Charu Sharma et al. CURRENT PHARMACEUTICAL DESIGN
- Protective effects of trans-caryophyllene on maintaining osteoblast function
- (2016) Jinghua Shan et al. IUBMB LIFE
- β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes
- (2016) Ryosuke Kamikubo et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Hypolipidemic effect of β-caryophyllene to treat hyperlipidemic rats
- (2016) Matheus D. Baldissera et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- β-Caryophyllene Attenuates Focal Cerebral Ischemia-Reperfusion Injury by Nrf2/HO-1 Pathway in Rats
- (2016) Jie Lou et al. NEUROCHEMICAL RESEARCH
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Beyond Cannabis: Plants and the Endocannabinoid System
- (2016) Ethan B. Russo TRENDS IN PHARMACOLOGICAL SCIENCES
- Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells
- (2016) Katrin Winkler et al. Oncotarget
- Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
- (2016) Lingjia Xu et al. Parkinsons Disease
- β-caryophyllene andβ-caryophyllene oxide-natural compounds of anticancer and analgesic properties
- (2016) Klaudyna Fidyt et al. Cancer Medicine
- Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
- (2016) Cathrin Rohleder et al. Frontiers in Pharmacology
- Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism
- (2016) Isabel González-Mariscal et al. Scientific Reports
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- β-Caryophyllene potently inhibits solid tumor growth and lymph node metastasis of B16F10 melanoma cells in high-fat diet–induced obese C57BL/6N mice
- (2015) Jae In Jung et al. CARCINOGENESIS
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10
- (2015) Rebecca H. Robinson et al. Journal of Neuroimmune Pharmacology
- Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
- (2015) Francieli Vuolo et al. MEDIATORS OF INFLAMMATION
- The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllene from the Essential Oil of Aquilaria crassna
- (2015) Saad Dahham et al. MOLECULES
- Cannabinoid receptor with an 'identity crisis' gets a second look
- (2015) Nala Rogers NATURE MEDICINE
- Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors
- (2015) Sahar El Swefy et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications
- (2015) Ashwini Rajasekaran et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- Activation of Cannabinoid Receptor 2 Enhances Osteogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells
- (2015) Yong-Xin Sun et al. Biomed Research International
- Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats
- (2014) Mona F. Mahmoud et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages
- (2014) M. N. M. Nogueira et al. INFLAMMATION RESEARCH
- Type-2 cannabinoid receptor regulates proliferation, apoptosis, differentiation, and OPG/RANKL ratio of MC3T3-E1 cells exposed to Titanium particles
- (2014) Shang Qiu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Unknown
- (2014) Jeremy Koppel et al. MOLECULAR MEDICINE
- Peripheral thermosensation in mammals
- (2014) Joris Vriens et al. NATURE REVIEWS NEUROSCIENCE
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats
- (2014) Hai-Ying Zhang et al. NEUROPSYCHOPHARMACOLOGY
- �-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway
- (2014) Yujie Cheng et al. PHARMACOLOGY
- β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
- (2014) Amine Bahi et al. PHYSIOLOGY & BEHAVIOR
- Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
- (2013) In-Young Choi et al. AMERICAN JOURNAL OF PATHOLOGY
- Activation of Cannabinoid Type 2 Receptor by JWH133 Protects Heart Against Ischemia/Reperfusion-Induced Apoptosis
- (2013) Qian Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Scleroderma: Nomenclature, etiology, pathogenesis, prognosis, and treatments: Facts and controversies
- (2013) Nicole Fett CLINICS IN DERMATOLOGY
- The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain
- (2013) A.-L. Klauke et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Identification of CB1/CB2 Ligands from Zanthoxylum bungeanum
- (2013) Katina S. S. Dossou et al. JOURNAL OF NATURAL PRODUCTS
- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+Cells Through PPARγ Involvement
- (2013) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- Cannabinoid receptor CB2 protects against balloon-induced neointima formation
- (2012) Filippo Molica et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription
- (2012) RB Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
- (2012) L. Soroceanu et al. CANCER RESEARCH
- CB1 Cannabinoid Receptor Activation Rescues Amyloid ß-Induced Alterations in Behaviour and Intrinsic Electrophysiological Properties of Rat Hippocampal CA1 Pyramidal Neurones
- (2012) Masoud Haghani et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Expression and distribution of TRPV2 in rat brain
- (2012) Thekkethil Prashant Nedungadi et al. EXPERIMENTAL NEUROLOGY
- CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients
- (2012) Maite Solas et al. NEUROBIOLOGY OF AGING
- The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABAA receptors
- (2012) Mikhail Alexeev et al. NEUROPHARMACOLOGY
- WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
- (2012) Gohar Fakhfouri et al. NEUROPHARMACOLOGY
- Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
- (2012) Leonora E. Long et al. PLoS One
- Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors
- (2012) F. S. den Boon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- (2011) Ethan B Russo BRITISH JOURNAL OF PHARMACOLOGY
- Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury
- (2011) Emanuela Esposito et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The genus Epimedium: An ethnopharmacological and phytochemical review
- (2011) Huiping Ma et al. JOURNAL OF ETHNOPHARMACOLOGY
- CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
- (2011) Emmanuel S Onaivi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy
- (2011) A. Shrivastava et al. MOLECULAR CANCER THERAPEUTICS
- A catalytically silent FAAH-1 variant drives anandamide transport in neurons
- (2011) Jin Fu et al. NATURE NEUROSCIENCE
- The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55
- (2011) Niklas Schuelert et al. NEUROSCIENCE LETTERS
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?
- (2011) P. Pacher et al. PROGRESS IN LIPID RESEARCH
- Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
- (2011) Juan G. Zarruk et al. STROKE
- The role of the endocannabinoid system in islet biology
- (2011) Máire E Doyle Current Opinion in Endocrinology Diabetes and Obesity
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
- (2010) Sean D. McAllister et al. BREAST CANCER RESEARCH AND TREATMENT
- Phytocannabinoids beyond the Cannabis plant - do they exist?
- (2010) J������rg Gertsch et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB2: a cannabinoid receptor with an identity crisis
- (2010) Brady K Atwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice
- (2010) Yan Zhao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The endocannabinoid system as a target for the treatment of neuronal damage
- (2010) Javier Fernández-Ruiz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules
- (2010) Yan Zhao et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis
- (2009) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- Cannabinoids in the treatment of cancer
- (2009) Amy Alexander et al. CANCER LETTERS
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
- (2009) Daniel K. Nomura et al. CELL
- Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors
- (2009) Alvin R. King et al. CHEMISTRY & BIOLOGY
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2009) David A. Price et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Species differences in cannabinoid receptor 2 (CNR2gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
- (2009) Q.-R. Liu et al. GENES BRAIN AND BEHAVIOR
- Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
- (2009) María Salazar et al. JOURNAL OF CLINICAL INVESTIGATION
- CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion
- (2009) Fabrizio Montecucco et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Beneficial effects of aCannabis sativaextract treatment on diabetes-induced neuropathy and oxidative stress
- (2009) Francesca Comelli et al. PHYTOTHERAPY RESEARCH
- Localisation and Function of the Endocannabinoid System in the Human Ovary
- (2009) Mona R. El-Talatini et al. PLoS One
- The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)
- (2008) Barbara L.F. Kaplan et al. BIOCHEMICAL PHARMACOLOGY
- Cannabinoids for Cancer Treatment: Progress and Promise
- (2008) S. Sarfaraz et al. CANCER RESEARCH
- Modulation of the Endocannabinoid System in Cardiovascular Disease
- (2008) Pál Pacher et al. HYPERTENSION
- Endocannabinoids and the Regulation of Bone Metabolism
- (2008) I. Bab et al. JOURNAL OF NEUROENDOCRINOLOGY
- Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review
- (2008) I SVIZENSKA et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- In silicoTarget Fishing for Rationalized Ligand Discovery Exemplified on Constituents ofRuta graveolens
- (2008) Judith Rollinger et al. PLANTA MEDICA
- Beta-caryophyllene is a dietary cannabinoid
- (2008) Jürg Gertsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation
- (2007) K L Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now